Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President ...

The vitiligo treatment landscape is evolving with a shift towards targeted therapies, which have shown encouraging results in promoting repigmentatio ...

After a slow 2024, the biotech shell company Concentra Biosciences is back, offering to buy four biotechs in the past month ...

Canadian doctors and scientists say Robert F. Kennedy Jr.'s defunding of mRNA vaccine research and development projects will ...

Back in favour as a trendy option, glass is the ideal packaging choice for the circular economy. Glass is supported by an established and efficient recycling systems. Driving this momentum is a ...

I am reversing my rating on Akero Therapeutics stock from Buy to Sell due to valuation concerns and a long-ish wait for ...

Details of external meetings held between April 2023 and March 2024 by NHS England national directors with non-NHS/non-public sector organisations.

According to the latest study from BCC Research, "Global Markets for Infectious Disease Treatments" is expected to grow from ...

The market for IBAT inhibitors is projected to experience significant growth in the near future, fueled by the rising incidence of genetic disorders, a strong pipeline of clinical trials, and ...

Communities Unite from September to November to Raise Awareness and Save Lives Together in TEAL brings us together as survivors, a ...

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into ...